Exploring how metal ions affect the CRISPR-Cas9 gene editing system
Investigating the metal-dependent function, allostery and inhibition of CRISPR-Cas9
This study is exploring how certain metal ions can change the way a gene-editing tool called CRISPR-Cas9 works, which could help improve treatments for genetic diseases by making gene editing more effective and controlled.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-11098272 on NIH RePORTER |
What this research studies
This research investigates the CRISPR-Cas9 technology, which is a powerful tool for editing genes to potentially treat genetic diseases. The project focuses on understanding how different metal ions influence the function of the Cas9 enzyme, which is crucial for cutting DNA. By using advanced computer simulations and theoretical methods, the researchers aim to uncover how these metal ions affect the enzyme's activity and how certain proteins can inhibit its function. This knowledge could lead to improved gene editing techniques and better control over gene regulation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic diseases that could potentially be treated with gene editing technologies.
Not a fit: Patients with conditions that are not amenable to gene editing or those who do not have genetic mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the precision and safety of CRISPR-Cas9 gene editing, leading to more effective treatments for genetic disorders.
How similar studies have performed: Previous research has shown promising results in enhancing CRISPR-Cas9 technology, indicating that this approach could lead to significant advancements in gene editing.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Palermo, Giulia — University of California Riverside
- Study coordinator: Palermo, Giulia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.